Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy
Authors:
Open Access
- 3 October 2012
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 24 (2) , 428-432
Abstract
The established treatment of limited-stage follicular lymphoma is radiotherapy (RT). There is an inherent risk of transformation of follicular lymphoma to aggressive lymphoma; however, the frequency and impact on the outcome are unknown in limited-stage patients. We identified 237 patients with limited-stage follicular lymphoma treated with curative intent RT. Cases were reviewed to determine the frequency of transformation and subsequent survival. With a median follow-up of 7.4 years, the 10-year risk of transformation was 18.5%. With a median follow-up after transformation of 4.7 years, the 3-year post-transformation progression-free survival (PFS) and overall survival (OS) were 42% and 44%, respectively. The addition of rituximab improved the 3-year post-transformation PFS and OS compared with combination chemotherapy alone (78% versus 15%, P < 0.00001) and (87% versus 38.5%, P < 0.00001), respectively. In multivariate analysis, only rituximab was associated with OS [HR 0.07 (95% CI 0.015–0.312, P = 0.001)] and PFS [HR 0.19 (95% CI 0.55–0.626, P = 0.007)] following transformation. There is a moderate risk of transformation in limited-stage follicular lymphoma treated with curative intent RT, and it substantially impacts outcome in these patients. Treatment with rituximab at the time of transformation appears to improve survival in this otherwise poor-risk population.Keywords
This publication has 42 references indexed in Scilit:
- Long‐term outcomes for patients with limited stage follicular lymphomaCancer, 2010
- Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Non-Hodgkin’s LymphomasJournal of the National Comprehensive Cancer Network, 2010
- Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Risk and Clinical Implications of Transformation of Follicular Lymphoma to Diffuse Large B-Cell LymphomaJournal of Clinical Oncology, 2007
- Long-term outcome and mortality trends in early-stage, Grade 1–2 follicular lymphoma treated with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.Journal of Clinical Oncology, 1996
- Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphomaRadiotherapy and Oncology, 1995
- Retrospective analysis of stage I and II indolent lymphomas at the National Cancer InstituteInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958